Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S.

The Agent paclitaxel-coated balloon was better than conventional balloon angioplasty for in-stent restenosis (ISR), according to the AGENT IDE pivotal trial that will be used to support the device's case for FDA approval in coronary circulation.